Isoflurane Differentially Modulates Mitochondrial Reactive Oxygen Species Production via Forward versus Reverse Electron Transport Flow
Open Access
- 1 September 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 115 (3) , 531-540
Abstract
Background: Reactive oxygen species (ROS) mediate the effects of anesthetic precondition to protect against ischemia and reperfusion injury, but the mechanisms of ROS generation remain unclear. In this study, the authors investigated if mitochondria-targeted antioxidant (mitotempol) abolishes the cardioprotective effects of anesthetic preconditioning. Further, the authors investigated the mechanism by which isoflurane alters ROS generation in isolated mitochondria and submitochondrial particles. Methods: Rats were pretreated with 0.9% saline, 3.0 mg/kg mitotempol in the absence or presence of 30 min exposure to isoflurane. Myocardial infarction was induced by left anterior descending artery occlusion for 30 min followed by reperfusion for 2 h and infarct size measurements. Mitochondrial ROS production was determined spectrofluorometrically. The effect of isoflurane on enzymatic activity of mitochondrial respiratory complexes was also determined. Results: Isoflurane reduced myocardial infarct size (40 ± 9% = mean ± SD) compared with control experiments (60 ± 4%). Mitotempol abolished the cardioprotective effects of anesthetic preconditioning (60 ± 9%). Isoflurane enhanced ROS generation in submitochondrial particles with nicotinamide adenine dinucleotide (reduced form), but not with succinate, as substrate. In intact mitochondria, isoflurane enhanced ROS production in the presence of rotenone, antimycin A, or ubiquinone when pyruvate and malate were substrates, but isoflurane attenuated ROS production when succinate was substrate. Mitochondrial respiratory experiments and electron transport chain complex assays revealed that isoflurane inhibited only complex I activity. Conclusions: The results demonstrated that isoflurane produces ROS at complex I and III of the respiratory chain via the attenuation of complex I activity. The action on complex I decreases unfavorable reverse electron flow and ROS release in myocardium during reperfusion.Keywords
This publication has 44 references indexed in Scilit:
- Monitoring mitochondrial electron fluxes using NAD(P)H-flavoprotein fluorometry reveals complex action of isoflurane on cardiomyocytesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Mitochondrial depolarization underlies delay in permeability transition by preconditioning with isoflurane: roles of ROS and Ca2+American Journal of Physiology-Cell Physiology, 2010
- Isoflurane protects cardiomyocytes and mitochondria by immediate and cytosol‐independent action at reperfusionBritish Journal of Pharmacology, 2010
- Differences in Production of Reactive Oxygen Species and Mitochondrial Uncoupling as Events in the Preconditioning Signaling Cascade Between Desflurane and SevofluraneAnesthesia & Analgesia, 2009
- Anesthetic-induced Preconditioning Delays Opening of Mitochondrial Permeability Transition Pore via Protein Kinase C-ϵ–mediated PathwayAnesthesiology, 2009
- Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and IIIBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Chemistry and Antihypertensive Effects of Tempol and Other NitroxidesPharmacological Reviews, 2008
- Different mechanisms of mitochondrial proton leak in ischaemia/reperfusion injury and preconditioning: implications for pathology and cardioprotectionBiochemical Journal, 2006
- Uncoupling Proteins 2 and 3 Function in Concert to Augment Tolerance to Cardiac IschemiaJournal of Biological Chemistry, 2005
- Determination of Experimental myocardial infarct sizeJournal of Pharmacological Methods, 1981